HomePTPI • NASDAQ
add
Petros Pharmaceuticals Inc
Previous close
$0.048
Day range
$0.042 - $0.049
Year range
$0.042 - $0.91
Market cap
2.55M USD
Avg Volume
65.70M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 725.40K | 299.15% |
Operating expense | 2.21M | -51.12% |
Net income | -9.27M | -3,014.80% |
Net profit margin | -1.28K | -1,363.68% |
Earnings per share | — | — |
EBITDA | -1.09M | 74.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.71M | -72.18% |
Total assets | 10.64M | -68.53% |
Total liabilities | 18.10M | -15.07% |
Total equity | -7.47M | — |
Shares outstanding | 53.52M | — |
Price to book | -0.07 | — |
Return on assets | -27.88% | — |
Return on capital | -84.19% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -9.27M | -3,014.80% |
Cash from operations | 965.40K | 142.72% |
Cash from investing | -5.45K | — |
Cash from financing | -1.14M | 51.76% |
Net change in cash | -184.71K | 96.01% |
Free cash flow | 3.19M | 4,488.32% |
About
Founded
2020
Website
Employees
18
